ABBOTT LABORATORIES Goodwill, Period Increase (Decrease)
ABBOTT LABORATORIES (ABT) reported Goodwill, Period Increase (Decrease) of $11.40 billion for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Notes › Goodwill and Other
us-gaap:GoodwillPeriodIncreaseDecrease · last filed 2026-04-29
- ABBOTT LABORATORIES goodwill, period increase (decrease) for the quarter ending 2026-03-31 was $11.40B.
- ABBOTT LABORATORIES goodwill, period increase (decrease) for the quarter ending 2023-12-31 was -$14.00M.
- ABBOTT LABORATORIES goodwill, period increase (decrease) for fiscal 2025 was $47.00M.
- ABBOTT LABORATORIES goodwill, period increase (decrease) for fiscal 2023 was $576.00M.
| Period end | Goodwill, Period Increase (Decrease) 3 month | Goodwill, Period Increase (Decrease) 9 month | Goodwill, Period Increase (Decrease) 12 month |
|---|---|---|---|
| 2026-03-31 | $11.40B 10-Q · filed 2026-04-29 | ||
| 2025-12-31 | $47.00M 10-K · filed 2026-02-20 | ||
| 2023-12-31 | -$14.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21 | $576.00M 10-K · filed 2025-02-21 | |
| 2023-09-30 | $590.00M 10-Q · filed 2023-11-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |